Nephrotoxicity assessment of Esculentoside A using human‐induced pluripotent stem cell‐derived organoids
Phytotherapy Research · 2024
DOI: 10.1002/ptr.7721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Shuyi Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China. Hauptthemen laut MEDLINE: Organoids, Saponins, Acute Kidney Injury, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Key Research and Development Program of The Ministry of Science and Technology project (Study on liver, Kidney and intestinal toxicity of Traditional…, National Natural Science Foundation of China.
Abstract (Originalsprache)
Drug‐induced nephrotoxicity is a leading cause of acute kidney injury (AKI). A major obstacle in predicting AKI is the lack of a comprehensive experimental model that mimics stable and physiologically relevant kidney functions and accurately reflects the changes a drug induces. Organoids derived from human‐induced pluripotent stem cells (iPSCs) are promising models because of their reproducibility and similarity to the in vivo conditions. In this study, Esculentoside A, the triterpene saponin with the highest concentration isolated from the root of Phytolacca acinose Roxb., was used to induce kidney injury models in vivo and kidney organoids. Esculentoside A induced AKI in mice, together with pathological changes and enhanced apoptosis. Moreover, Esculentoside A damaged podocytes and proximal tubular endothelial cells in kidney organoids in a similar way as in vivo. We also found that treatment with 60 μM Esculentoside A induced the known biomarkers of kidney damage and inflammatory cytokines (such as kidney injury molecule (KIM‐1), β2‐microglobulin (β2‐M), and cystatin C (CysC)) in the organoids, in which activation of Cleaved Caspase‐3 was involved, possibly due to lowered mitochondrial membrane potential. In summary, this study strongly suggests using kidney organoids as a reliable platform to assess Chinese medicine‐induced nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China.
- Shanghai Frontiers Science Center of TCM Chemical Biology, Shanghai, PR China.
- Pharmacology and Toxicology Department, Shanghai Institute for Food and Drug Control, Shanghai, PR China.
ORCID-Profile: Shuyi Gu
Förderung
- National Key Research and Development Program of The Ministry of Science and Technology project (Study on liver, Kidney and intestinal toxicity of Traditional…
- National Natural Science Foundation of China
Zitieren
APA
Gu, S., Wu, G., Lu, D., Meng, G., Wang, Y., Tang, L., & Zhang, W. (2024). Nephrotoxicity assessment of Esculentoside A using human‐induced pluripotent stem cell‐derived organoids. Phytotherapy Research. https://doi.org/10.1002/ptr.7721
Vancouver
Gu S, Wu G, Lu D, Meng G, Wang Y, Tang L, et al. Nephrotoxicity assessment of Esculentoside A using human‐induced pluripotent stem cell‐derived organoids. Phytotherapy Research. 2024. doi:10.1002/ptr.7721
BibTeX
@article{Gu2024,
author = {Gu, Shuyi and Wu, Gaosong and Lu, Dong and Meng, Guofeng and Wang, Yu and Tang, Liming and Zhang, Weidong},
title = {Nephrotoxicity assessment of Esculentoside A using human‐induced pluripotent stem cell‐derived organoids},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.7721}
}
EUVIMED